IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024 LAWRENCEVILLE, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...